Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

750
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study.

Lancet (London, England)·2026
Same author

4-weekly avelumab plus axitinib in patients with metastatic renal cell carcinoma.

BJC reports·2026
Same author

Ethnicity and Heart Failure Outcomes in England: Role of Specialist Care in a Universal Health System.

Journal of the American College of Cardiology·2026
Same author

Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial Portfolio.

European journal of heart failure·2026
Same author

SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure.

European journal of heart failure·2026
Same author

Post-COVID-19 era heart failure diagnosis and outcomes: adherence to National Institute for Health and Care Excellence Guidelines.

Open heart·2026

Related Experiment Video

Updated: Apr 23, 2026

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
14:28

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care

Published on: May 10, 2024

2.9K

Biomarkers in mechanical circulatory support.

Joanne Simpson1, Colette E Jackson, Roy S Gardner

  • 1Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

Biomarkers in Medicine
|September 17, 2014
PubMed
Summary

Mechanical circulatory support offers a new therapy for advanced heart failure. This review examines biomarkers related to mechanical circulatory support and identifies future research directions for heart failure treatment.

Keywords:
biomarkerheart failureleft ventricular assist devicemechanical circulatory supportrecovery

More Related Videos

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K

Related Experiment Videos

Last Updated: Apr 23, 2026

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care
14:28

Non-Invasive Monitoring of Microvascular Oxygenation and Reactive Hyperemia using Hybrid, Near-Infrared Diffuse Optical Spectroscopy for Critical Care

Published on: May 10, 2024

2.9K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.4K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K

Area of Science:

  • Cardiology
  • Biomarker Research
  • Medical Technology

Background:

  • Heart failure (HF) is a complex syndrome with high mortality and hospitalization rates despite pharmacological treatments.
  • The progressive nature of HF often leads to end-stage disease, with orthotopic heart transplantation being a limited resource option.
  • Mechanical circulatory support (MCS) has emerged as a significant therapy for advanced heart failure patients.

Purpose of the Study:

  • To review existing data on biomarkers in patients receiving mechanical circulatory support.
  • To identify current research trends and potential future directions in MCS biomarker research.
  • To enhance understanding of HF pathophysiology and treatment efficacy through biomarker analysis.

Main Methods:

  • Comprehensive literature review of published data on biomarkers in MCS.
  • Analysis of studies focusing on the role of various biomarkers in HF patients with MCS.
  • Identification of key research areas and emerging trends in the field.

Main Results:

  • Biomarkers play a crucial role in assessing the efficacy and outcomes of MCS.
  • Specific biomarkers are associated with patient selection, device performance, and complication monitoring in MCS.
  • The review highlights the evolving landscape of biomarker utility in advanced HF management.

Conclusions:

  • Biomarkers are essential for optimizing the use of mechanical circulatory support in heart failure.
  • Further research is needed to validate and integrate novel biomarkers into clinical practice for MCS patients.
  • Understanding biomarker profiles can guide personalized treatment strategies and improve outcomes in advanced heart failure.